BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD3974 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD3974\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07290283-11157@assetmemo.bio
DTSTAMP:20261121T005414Z
DTSTART;VALUE=DATE:20261208
DTEND;VALUE=DATE:20261209
SUMMARY:AZD3974: Phase 1 readout est. (NCT07290283)
DESCRIPTION:AZD3974\, phase 1.\nStudy: A Study to Investigate Safety\, Tole
 rability\, and Pharmacokinetics of AZD3974 in Healthy Participants\nEstima
 ted primary completion: 8 December 2026. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/azd3974#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT07290283
URL:https://assetmemo.bio/drug/azd3974#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
